Across New England and the country, thousands of budding scientists have awoken to a stark new reality, following funding ...

HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...

A U.S. senator is asking the FDA how it will enforce regulations on pharmaceutical advertising after it let go of numerous ...

The custom-built gene editing treatment for 6-month-old KJ Muldoon could not have come at a more welcome or jarring time for ...

In today's D.C. Diagnosis newsletter, layoffs hit the National Academies, and a look at what's already been lost from firings ...

Last week, I was flipping through the newly filed financial documents of AdventHealth, and the numbers hit me like an ...

A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.

Digital physical therapy company Hinge Health went public last week, raising $437 million and ending an IPO drought for ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

Harvard's Scott Delaney helped build a database of NIH grant terminations that is being used in litigation against the Trump ...

Earlier gatherings focused on gaining public acceptance for what scientists want to do with CRISPR. This meeting flipped that ...

As a public health official, Jay K. Varma has handled putative anthrax attacks. He says an AI-simulated bioterror attack ...